Aanchal Ispat: Company Secretary Resigns Effective October 5

Aanchal Ispat Limited has announced the resignation of Mr. Puspendu Kayal from his positions as Company Secretary and Compliance Officer. His resignation is effective from the close of business hours on October 5, 2026, citing personal and career reasons. The company received the resignation letter on September 12, 2026, and it will be placed before the Board for formal acceptance. The company will complete necessary statutory filings in accordance with regulations.

Key Management Change at Aanchal Ispat

Aanchal Ispat Limited has formally informed stakeholders about the resignation of Mr. Puspendu Kayal from his roles as Company Secretary and Compliance Officer. This announcement was made in accordance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Resignation Details

Mr. Kayal tendered his resignation on September 12, 2026, and it will be effective from the closure of business hours on October 5, 2026. The company cited personal and career reasons for his departure. The resignation letter was received by the company on the same day it was tendered.

Board and Regulatory Procedures

The resignation of Mr. Puspendu Kayal will be presented to the Board of Directors for formal acceptance during an upcoming Board Meeting. This process ensures compliance with the Companies Act, 2013, and the SEBI LODR Regulations. Aanchal Ispat Limited will undertake all necessary statutory filings and procedures to reflect this change in key managerial personnel.

Annexure II: Disclosure of Changes

As per Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the following details are disclosed regarding the change:

  • Reason for Change: Resignation of Mr. Puspendu Kayal from the position of Company Secretary and Compliance Officer due to personal and career reasons.
  • Effective Date: Cessation with effect from October 5, 2026.
  • Brief Profile: Not applicable as it pertains to resignation.
  • Relationships: Not applicable as no new director is being appointed.

Source: BSE

Previous Article

Dishman Carbogen Amcis: Subsidiary Clears US FDA Inspection with No Observations